Clinical Trials Directory

Trials / Unknown

UnknownNCT01976117

E-nose Utility in the Diagnosis of Bacterial Infection in COPD

E-nose Utility in the Diagnosis of Bacterial Infection in Chronic Obstructive Pulmonary Disease (COPD)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Hypothesis: A commercial e-nose (Cyranose 320) is able to detect specific breathprints from patients with COPD and bacterial infection

Detailed description

Thirty to 50% of COPD patients have airway colonization with potentially pathogenic bacteria. This is associated with worse prognosis. Currently, diagnosis of bacterial colonization relies mainly upon quantitative sputum culture. However, this method lacks good sensitivity. The electronic nose is a novel device made up of nanosensors capable of detecting specific volatile organic compounds (VOCs). OBJECTIVES: Main 1) To assess the usefulness of the electronic nose in the diagnosis of bacterial colonization in COPD. Secondary 1) To define the VOCs pattern associated with bacterial colonization. 2) To study the pattern of pulmonary and systemic inflammation associated with bacterial colonization as well its relationship with the aforementioned VOCs patterns.

Conditions

Interventions

TypeNameDescription
DEVICEenose

Timeline

Start date
2012-06-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2013-11-05
Last updated
2016-09-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01976117. Inclusion in this directory is not an endorsement.